Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Could Release GMP Data To Prod Manufacturing Improvements

This article was originally published in The Pink Sheet Daily

Executive Summary

Batch failure and other measures commonly tracked by manufacturers could be aggregated into an industry-wide index that FDA would use to help make risk-based inspection decisions.


Related Content

US FDA Quality Metrics Initiative Continues Moving Forward … Quietly
FDA Mutual Reliance with EU on Inspections Is Slow Going
FDA Mutual Reliance With EU On Inspections Is Slow Going
Budget Reductions Target FDA Field Operations
Budget Reductions Target FDA Field Operations
FDA May Require Drug Importers To Verify Product Quality
FDASIA Is Signed, Not That White House Wanted Anyone To Notice
GMP Carrots For Quality: FDA Considers Incentives To Adopt Quality Systems
FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues
FDA-EMA-TGA Joint Inspection Program To Be Permanent; Other Collaborations Expand





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts